1. Home
  2. ENTX vs SELF Comparison

ENTX vs SELF Comparison

Compare ENTX & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.69

Market Cap

58.2M

Sector

Health Care

ML Signal

HOLD

Logo Global Self Storage Inc.

SELF

Global Self Storage Inc.

HOLD

Current Price

$5.23

Market Cap

58.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTX
SELF
Founded
2010
1983
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
58.2M
58.0M
IPO Year
2015
1997

Fundamental Metrics

Financial Performance
Metric
ENTX
SELF
Price
$1.69
$5.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$9.00
$6.00
AVG Volume (30 Days)
2.9M
13.5K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
5.25%
EPS Growth
N/A
N/A
EPS
0.07
0.04
Revenue
$42,000.00
$12,705,245.00
Revenue This Year
N/A
$3.04
Revenue Next Year
N/A
$3.47
P/E Ratio
$23.71
$129.25
Revenue Growth
N/A
1.40
52 Week Low
$0.91
$4.73
52 Week High
$3.22
$5.63

Technical Indicators

Market Signals
Indicator
ENTX
SELF
Relative Strength Index (RSI) 63.26 51.01
Support Level $1.45 $4.96
Resistance Level $1.94 $5.27
Average True Range (ATR) 0.28 0.11
MACD 0.02 0.01
Stochastic Oscillator 30.87 64.29

Price Performance

Historical Comparison
ENTX
SELF

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

About SELF Global Self Storage Inc.

Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.

Share on Social Networks: